The gap between swallowing and absorbing
Most people who take supplements do so consistently and conscientiously — the right product, the right dose, the right time of day. And yet, for many, the expected change never quite arrives. Energy remains flat. Recovery plateaus. The gap between effort and outcome stays stubbornly wide.
It is tempting to assume the answer is simply a higher dose. But there is an important step that supplement labels rarely address: the distance between a nutrient entering your mouth and that same nutrient arriving at target tissue in a form your cells can actually use. Those two events are not the same thing, and the route between them is far more complicated than most marketing suggests.
The ingredient listed on the packet is what you consumed. What matters physiologically is how much of it cleared the digestive system, survived the liver's first pass, and reached the bloodstream in an active state. That fraction is called bioavailability — and it is the variable that dose alone cannot fix.
What bioavailability actually means
Think of bioavailability as a delivery rate, not a fixed property of the nutrient itself. Intravenous delivery sits at the top of that scale — 100% — because it places the substance directly into systemic circulation, skipping every barrier the body might otherwise impose. That ceiling is useful not as a sales argument but as a scientific reference point: it tells you the maximum the body could theoretically receive, against which every other route can be measured.
Oral delivery operates well below that ceiling, and the gap is not fixed — it shifts depending on the nutrient, the individual, and the circumstances. Stomach acid degrades some compounds before they can be absorbed. The gut wall filters what crosses it. Then the liver processes whatever arrives, stripping out a further proportion before it enters general circulation. This sequence — collectively known as first-pass metabolism — is not a malfunction; it is the body behaving exactly as designed, prioritising caution over convenience.
The practical implication is that the dose on a supplement label and the dose your cells receive are two different numbers. Understanding why those numbers diverge is where a more useful conversation about supplementation can begin.
Free non-medical discussion
Not sure what to do next?
Information only · No medical advice or diagnosis.
Why the body breaks down so much of what you swallow
The first-pass effect is only the opening act. Several other structural factors compound the loss — and together they explain why oral supplementation can be an unreliable delivery system even for carefully chosen products.
Chemical form is perhaps the least visible variable. Not all versions of the same nutrient behave identically once they enter the body. Methylfolate — the form of folate that cells can use directly — is absorbed far more efficiently than folic acid, which requires an enzymatic conversion step that not everyone completes effectively. Calcifediol, one form of vitamin D, reaches systemic circulation more readily than the more widely used cholecalciferol. The dose on the label stays constant; the fraction that actually reaches target tissue does not.
The food matrix introduces further complexity. Vitamins A, D, E, and K are fat-soluble: without co-ingested dietary fat, they largely pass through the gut unused. Taking a vitamin D capsule with water on an empty stomach is a very different biological event from taking it with a fat-containing meal. Nutrient competition adds another layer — high-dose calcium can inhibit iron and zinc absorption when taken at the same time, and calcium and magnesium share intestinal transport pathways.
Gut microbiome health directly modulates how much gets through. A well-functioning gut microbiota actively supports uptake of vitamins and minerals; dysbiosis — disrupted microbial balance — measurably reduces the availability of several of them. Inflammation or intestinal damage impairs the villi responsible for transport across the gut wall.
Age tightens all of these constraints progressively. Older adults absorb B12, vitamin D, and calcium less efficiently than younger people — so the same supplement dose taken at 45 and at 65 may produce meaningfully different outcomes in the bloodstream. For a reader in the 40–70+ bracket, that is not a future concern; it is already a present variable.
When delivery form outweighs the dose on the label
Two nutrients illustrate the delivery problem more sharply than any abstract principle can.
Coenzyme Q10 — a compound central to mitochondrial energy production and a frequent target of performance and recovery supplementation — is water-insoluble by nature. That single chemical property creates what researchers describe as a 'major hindrance to successful supplementation': standard oral forms struggle to reach systemic circulation at meaningful concentrations regardless of the dose listed on the bottle. Liposomes, nanoemulsions, and protein-complexed formulations have all been studied as routes to improve delivery, with measurable gains in systemic availability reported for several approaches — though CoQ10 remains a compound where form matters far more than milligrams.
Vitamin C tells a similar story from a different angle. A 2025 systematic review across 13 trials found that alternative formulations — particularly liposomal-encapsulated ascorbic acid — consistently produced higher plasma concentrations and better cellular retention than standard ascorbic acid at equivalent doses. The active ingredient was identical; the vehicle carrying it was not. That difference, replicated across multiple studies, is the clearest available demonstration that dose and delivery are separate variables.
Beyond these two cases, vitamins D, A, E, K, B12, and folate all face the same compounding set of obstacles: poor solubility, breakdown during GI transit, and first-pass hepatic metabolism. Nanocarrier-based delivery research is aimed precisely at this cluster of problems, though it remains largely at research stage rather than being widely available in consumer products.
A useful caution sits alongside all of this: enhanced-bioavailability claims in the supplement market are sometimes overstated relative to the actual trial evidence. The science of delivery form is genuine; not every premium formulation on a health-store shelf has earned the claim. Reading a label for dose alone gives an incomplete picture — but so does accepting absorption claims uncritically.
Professor Paul Lee's Chemistry pillar — precision delivery over more pills
The logical endpoint of that absorption evidence is a simple engineering question: if the GI tract is the rate-limiting variable, what changes when you remove it entirely?
Intravenous delivery sets bioavailability at 100% — not as a marketing claim but as a physiological constant. A nutrient delivered directly into systemic circulation bypasses the first-pass effect, the food-matrix dependency, the microbiome condition, and the solubility barrier simultaneously. The dose listed equals the dose received.
Professor Paul Lee formalises this logic in Practical Regeneration (February 2026), the applied companion to Regeneration by Design. In the Chemistry pillar chapter — 'Pillar 2: The Invisible War' — he writes that 'most oral supplements never reach full effectiveness due to digestive breakdown and absorption limits,' and argues that once foundational nutrition is established, precision delivery, not more pills, is the variable that determines whether nutrients actually reach the cells that need them. It is an engineer-surgeon's response to a systems problem: identify the limiting step and address it at the mechanism.
The Regen365™ IV platform puts this reasoning into practice — pharmaceutical-grade nutrients administered intravenously by a trained clinician in approximately twenty minutes, bypassing GI absorption entirely. It is designed as a wellness support protocol for recovery and performance optimisation, not as a substitute for foundational nutrition. Independent head-to-head trial data comparing IV delivery against optimised oral forms for specific nutrients remains limited; the case rests on the physiological mechanism itself, which is unambiguous: a nutrient already in the bloodstream has nothing left to lose in transit.
What this means for how you actually supplement
Three adjustments require no prescription, no expensive reformulation, and no waiting.
Read for form, not just dose. Methylfolate rather than folic acid; calcifediol rather than cholecalciferol — these are chemically distinct compounds with meaningfully different absorption profiles. A label reading takes thirty seconds and changes what you actually receive.
Match fat-soluble vitamins to a fat-containing meal. Vitamins A, D, E, and K require dietary fat to be absorbed — the timing of the meal is part of the dose. This is one of the few interventions in nutrition where the mechanism is settled and the adjustment is free.
Treat gut health as part of the supplementation equation, not separate from it. A compromised microbiome measurably reduces absorptive capacity for several key nutrients. Dietary diversity, sleep, and managing chronic inflammation all have direct consequences for how much of what you swallow makes it to circulation.
If you are in the 40–70+ bracket, it is also worth revisiting dosing assumptions formed years earlier. Absorptive capacity for B12, D, and calcium declines with age — adequate intake on paper may no longer translate to adequate intake at the cell.
For those with strong nutritional foundations who want to move beyond what oral supplementation can reliably deliver for specific nutrients, intravenous delivery represents a different tier of support — an advanced adjunct, not a starting point, and one that works precisely because it sidesteps the entire set of barriers explored in this article. It is not a universal recommendation; it is a tool for a specific stage of the system.
These are population-level patterns, and individual absorptive capacity varies considerably. Anyone managing a health condition or considering a material change to their supplementation should take that decision in conversation with a qualified healthcare professional.
Dose alone has never been the whole question. What actually reaches the cell is.
- [1] Bioavailability. https://en.wikipedia.org/?curid=769021 https://en.wikipedia.org/?curid=769021
- [2] First pass effect. https://en.wikipedia.org/?curid=1173539 https://en.wikipedia.org/?curid=1173539
- [3] Oral Bioavailability Enhancement Through Lipid Polymer Hybrid Nanoparticles. (2025). https://doi.org/10.3390/pharmaceutics17030381 https://doi.org/10.3390/pharmaceutics17030381
- [4] Bioavailability enhancement of coenzyme Q10: An update of novel approaches. (2024). https://doi.org/10.1002/ardp.202300676 https://doi.org/10.1002/ardp.202300676
- [5] Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults. (2025). https://doi.org/10.3390/nu17020279 https://doi.org/10.3390/nu17020279
- [6] Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. (2022). https://doi.org/10.3390/biomedicines10092055 https://doi.org/10.3390/biomedicines10092055
- [7] Advances in Nanoparticle-Based Vitamin Delivery Systems for Precision Nutrition and Improved Bioavailability. (2026). https://doi.org/10.1208/s12249-026-03410-w https://doi.org/10.1208/s12249-026-03410-w
